ID CXL14_HUMAN Reviewed; 111 AA. AC O95715; B3KQU8; Q6UW97; Q86U69; Q9BTR1; Q9NS21; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 23-MAR-2010, sequence version 2. DT 13-FEB-2019, entry version 156. DE RecName: Full=C-X-C motif chemokine 14; DE AltName: Full=Chemokine BRAK; DE AltName: Full=MIP-2G; DE AltName: Full=Small-inducible cytokine B14; DE Flags: Precursor; GN Name=CXCL14; Synonyms=MIP2G, NJAC, SCYB14; GN ORFNames=PSEC0212, UNQ240/PRO273; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION. RC TISSUE=Oral epithelium; RX PubMed=10854217; DOI=10.1016/S0002-9440(10)65067-5; RA Frederick M.J., Henderson Y., Xu X., Deavers M.T., Sahin A.A., Wu H., RA Lewis D.E., El-Naggar A.K., Clayman G.L.; RT "In vivo expression of the novel CXC chemokine BRAK in normal and RT cancerous human tissue."; RL Am. J. Pathol. 156:1937-1950(2000). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 35-44, FUNCTION, AND RP TISSUE SPECIFICITY. RX PubMed=10946286; DOI=10.4049/jimmunol.165.5.2588; RA Cao X., Zhang W., Wan T., He L., Chen T., Yuan Z., Ma S., Yu Y., RA Chen G.; RT "Molecular cloning and characterization of a novel CXC chemokine RT macrophage inflammatory protein-2 gamma chemoattractant for human RT neutrophils and dendritic cells."; RL J. Immunol. 165:2588-2595(2000). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=12975309; DOI=10.1101/gr.1293003; RA Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., RA Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., RA Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., RA Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., RA Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J., RA Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A., RA Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H., RA Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D., RA Wood W.I., Godowski P.J., Gray A.M.; RT "The secreted protein discovery initiative (SPDI), a large-scale RT effort to identify novel human secreted and transmembrane proteins: a RT bioinformatics assessment."; RL Genome Res. 13:2265-2270(2003). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Embryo; RX PubMed=16303743; DOI=10.1093/dnares/12.2.117; RA Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J., RA Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S., RA Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y., RA Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S., RA Isogai T.; RT "Signal sequence and keyword trap in silico for selection of full- RT length human cDNAs encoding secretion or membrane proteins from oligo- RT capped cDNA libraries."; RL DNA Res. 12:117-126(2005). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., RA Phelan M., Farmer A.; RT "Cloning of human full-length CDSs in BD Creator(TM) system donor RT vector."; RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15372022; DOI=10.1038/nature02919; RA Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., RA Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., RA She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S., RA Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M., RA Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., RA Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M., RA Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K., RA Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C., RA Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M., RA Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A., RA Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M., RA Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M., RA Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S., RA Richardson P., Lucas S.M., Myers R.M., Rubin E.M.; RT "The DNA sequence and comparative analysis of human chromosome 5."; RL Nature 431:268-274(2004). RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Pancreas; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP NUCLEOTIDE SEQUENCE [MRNA] OF 13-111, FUNCTION, AND TISSUE RP SPECIFICITY. RX PubMed=10049774; DOI=10.1006/bbrc.1999.0257; RA Hromas R., Broxmeyer H.E., Kim C., Nakshatri H., Christopherson K. II, RA Azam M., Hou Y.-H.; RT "Cloning of BRAK, a novel divergent CXC chemokine preferentially RT expressed in normal versus malignant cells."; RL Biochem. Biophys. Res. Commun. 255:703-706(1999). RN [9] RP STRUCTURE BY NMR OF 34-111, DOMAIN D-BOX MOTIF, UBIQUITINATION, AND RP DISULFIDE BONDS. RX PubMed=16987528; DOI=10.1016/j.jmb.2006.08.057; RA Peterson F.C., Thorpe J.A., Harder A.G., Volkman B.F., Schwarze S.R.; RT "Structural determinants involved in the regulation of CXCL14/BRAK RT expression by the 26 S proteasome."; RL J. Mol. Biol. 363:813-822(2006). CC -!- FUNCTION: Potent chemoattractant for neutrophils, and weaker for CC dendritic cells. Not chemotactic for T-cells, B-cells, monocytes, CC natural killer cells or granulocytes. Does not inhibit CC proliferation of myeloid progenitors in colony formation assays. CC {ECO:0000269|PubMed:10049774, ECO:0000269|PubMed:10946286}. CC -!- INTERACTION: CC O00585:CCL21; NbExp=2; IntAct=EBI-2798068, EBI-953695; CC Q9Y258:CCL26; NbExp=2; IntAct=EBI-2798068, EBI-7783416; CC P13501:CCL5; NbExp=2; IntAct=EBI-2798068, EBI-2848366; CC O14625:CXCL11; NbExp=2; IntAct=EBI-2798068, EBI-2871971; CC P48061:CXCL12; NbExp=2; IntAct=EBI-2798068, EBI-3913254; CC Q07325:CXCL9; NbExp=2; IntAct=EBI-2798068, EBI-3911467; CC P02776:PF4; NbExp=3; IntAct=EBI-2798068, EBI-2565740; CC Q8IYF3:TEX11; NbExp=3; IntAct=EBI-2798068, EBI-742397; CC P36406:TRIM23; NbExp=3; IntAct=EBI-2798068, EBI-740098; CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Expressed in heart, brain, placenta, lung, CC liver, skeletal muscle, kidney and pancreas. Highly expressed in CC normal tissue without inflammatory stimuli and infrequently CC expressed in cancer cell lines. Weakly expressed in monocyte- CC derived dendritic cells. Not detected in lung or unstimulated CC peripheral blood lymphocytes. {ECO:0000269|PubMed:10049774, CC ECO:0000269|PubMed:10854217, ECO:0000269|PubMed:10946286}. CC -!- INDUCTION: Up-regulated in peripheral blood lymphocytes in CC response to bacterial lipopolysaccharides (LPS). CC {ECO:0000269|PubMed:10854217}. CC -!- DOMAIN: The destruction box (D-box) acts as a recognition signal CC for degradation via the ubiquitin-proteasome pathway. CC {ECO:0000269|PubMed:16987528}. CC -!- PTM: Ubiquitinated, followed by degradation by the proteasome. CC {ECO:0000269|PubMed:16987528}. CC -!- SIMILARITY: Belongs to the intercrine alpha (chemokine CxC) CC family. {ECO:0000305}. CC -!- CAUTION: It is uncertain whether Met-1 or Met-13 is the initiator. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAD38944.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC -!- WEB RESOURCE: Name=Wikipedia; Note=CXCL14 entry; CC URL="https://en.wikipedia.org/wiki/CXCL14"; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC ----------------------------------------------------------------------- DR EMBL; AF144103; AAD38944.1; ALT_INIT; mRNA. DR EMBL; AF106911; AAF78449.1; -; mRNA. DR EMBL; AY358906; AAQ89265.1; -; mRNA. DR EMBL; AK075514; BAG52160.1; -; mRNA. DR EMBL; BT007080; AAP35743.1; -; mRNA. DR EMBL; AC034206; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC003513; AAH03513.1; -; mRNA. DR EMBL; AF073957; AAD03839.1; -; mRNA. DR CCDS; CCDS4188.1; -. DR PIR; JG0182; JG0182. DR RefSeq; NP_004878.2; NM_004887.4. DR UniGene; Hs.483444; -. DR PDB; 2HDL; NMR; -; A=35-111. DR PDBsum; 2HDL; -. DR ProteinModelPortal; O95715; -. DR SMR; O95715; -. DR BioGrid; 114921; 6. DR DIP; DIP-61148N; -. DR IntAct; O95715; 26. DR MINT; O95715; -. DR STRING; 9606.ENSP00000337065; -. DR iPTMnet; O95715; -. DR PhosphoSitePlus; O95715; -. DR BioMuta; CXCL14; -. DR jPOST; O95715; -. DR PaxDb; O95715; -. DR PeptideAtlas; O95715; -. DR PRIDE; O95715; -. DR ProteomicsDB; 51009; -. DR DNASU; 9547; -. DR Ensembl; ENST00000337225; ENSP00000337065; ENSG00000145824. DR GeneID; 9547; -. DR KEGG; hsa:9547; -. DR UCSC; uc003lay.4; human. DR CTD; 9547; -. DR DisGeNET; 9547; -. DR EuPathDB; HostDB:ENSG00000145824.12; -. DR GeneCards; CXCL14; -. DR HGNC; HGNC:10640; CXCL14. DR HPA; CAB029996; -. DR MIM; 604186; gene. DR neXtProt; NX_O95715; -. DR OpenTargets; ENSG00000145824; -. DR PharmGKB; PA35571; -. DR eggNOG; ENOG410J0K5; Eukaryota. DR eggNOG; ENOG4111XWS; LUCA. DR GeneTree; ENSGT00390000000618; -. DR HOGENOM; HOG000065700; -. DR HOVERGEN; HBG054250; -. DR InParanoid; O95715; -. DR KO; K10033; -. DR OMA; EGSKCKC; -. DR OrthoDB; 1504765at2759; -. DR PhylomeDB; O95715; -. DR TreeFam; TF332769; -. DR ChiTaRS; CXCL14; human. DR EvolutionaryTrace; O95715; -. DR GenomeRNAi; 9547; -. DR PRO; PR:O95715; -. DR Proteomes; UP000005640; Chromosome 5. DR Bgee; ENSG00000145824; Expressed in 221 organ(s), highest expression level in zone of skin. DR ExpressionAtlas; O95715; baseline and differential. DR Genevisible; O95715; HS. DR GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW. DR GO; GO:0005794; C:Golgi apparatus; IDA:LIFEdb. DR GO; GO:0008009; F:chemokine activity; TAS:ProtInc. DR GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IDA:UniProtKB. DR GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc. DR GO; GO:0006935; P:chemotaxis; TAS:ProtInc. DR GO; GO:0006955; P:immune response; IEA:InterPro. DR GO; GO:0048839; P:inner ear development; IEA:Ensembl. DR GO; GO:0031640; P:killing of cells of other organism; IDA:UniProtKB. DR GO; GO:0045662; P:negative regulation of myoblast differentiation; IEA:Ensembl. DR GO; GO:2000503; P:positive regulation of natural killer cell chemotaxis; IEA:Ensembl. DR GO; GO:0007165; P:signal transduction; TAS:ProtInc. DR InterPro; IPR001811; Chemokine_IL8-like_dom. DR InterPro; IPR039088; CXCL14. DR InterPro; IPR036048; Interleukin_8-like_sf. DR PANTHER; PTHR15188; PTHR15188; 1. DR Pfam; PF00048; IL8; 1. DR SUPFAM; SSF54117; SSF54117; 1. PE 1: Evidence at protein level; KW 3D-structure; Chemotaxis; Complete proteome; Cytokine; KW Direct protein sequencing; Disulfide bond; Reference proteome; KW Secreted; Signal; Ubl conjugation. FT SIGNAL 1 34 {ECO:0000269|PubMed:10946286}. FT CHAIN 35 111 C-X-C motif chemokine 14. FT /FTId=PRO_0000005115. FT MOTIF 67 81 D-box. FT DISULFID 37 63 {ECO:0000269|PubMed:16987528}. FT DISULFID 39 84 {ECO:0000269|PubMed:16987528}. FT CONFLICT 108 108 V -> F (in Ref. 2; AAF78449). FT {ECO:0000305}. FT STRAND 41 44 {ECO:0000244|PDB:2HDL}. FT HELIX 48 50 {ECO:0000244|PDB:2HDL}. FT STRAND 51 56 {ECO:0000244|PDB:2HDL}. FT STRAND 63 65 {ECO:0000244|PDB:2HDL}. FT STRAND 68 72 {ECO:0000244|PDB:2HDL}. FT STRAND 74 76 {ECO:0000244|PDB:2HDL}. FT TURN 77 80 {ECO:0000244|PDB:2HDL}. FT STRAND 81 85 {ECO:0000244|PDB:2HDL}. FT HELIX 90 106 {ECO:0000244|PDB:2HDL}. SQ SEQUENCE 111 AA; 13078 MW; C9A18B2A78CACF74 CRC64; MSLLPRRAPP VSMRLLAAAL LLLLLALYTA RVDGSKCKCS RKGPKIRYSD VKKLEMKPKY PHCEEKMVII TTKSVSRYRG QEHCLHPKLQ STKRFIKWYN AWNEKRRVYE E //